The European Union's drug regulator has recommended approval of Moderna's updated formulation of COVID-19 shot Spikevax, the ...

As Covid cases are ramping up once again this summer, it’s natural to start thinking of the risks and wonder if it’s time to ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two COVID-19 vaccines.

Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

The new shots won’t be available until the fall, and are expected to be approved only for adults 65 and up and kids and ...

Moderna's COVID-19 vaccine has received full approval from the U.S. Food and Drug Administration (FDA) for use in children ...

Robert F. Kennedy Jr.’s leadership at Health and Human Services has led to changes in vaccine recommendations and access, ...

FDA grants full approval to Moderna's COVID-19 vaccine for children aged 6 months to 11 years with medical vulnerabilities, marking a shift from emergency use to selective eligibility.

The U.S. Food and Drug Administration has granted full approval for Moderna's MRNA.O COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the ...

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company’s existing shot, but a second option.

WASHINGTON — The government’s top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently restricted the approval of two covid-19 vaccines, disregarding recommendations ...